Nicholas Investment Partners’s Guardant Health GH Stock Holding History
Bought
Maintained
Sold
Other funds holding GH
DTC
Nicholas Investment Partners's GH Position: Q2 2026 in Review
Nicholas Investment Partners sold out of Guardant Health (GH) in Q2 2026, closing a stake of 11,786 shares — an estimated $1.09M sold.
Nicholas Investment Partners first reported a position in GH in Q2 2019 and held it in 17 quarters. The position peaked at $23.6M in Q1 2021. 600 funds tracked by Wall St. Rank hold GH as of Q2 2026.
- Nicholas Investment Partners reported no remaining Guardant Health position as of Q2 2026 after selling out during the quarter.
- Nicholas Investment Partners sold 11,786 Guardant Health shares in Q2 2026, an estimated $1.09M.
- Nicholas Investment Partners first reported a position in Guardant Health in Q2 2019 and held it in 17 quarters.
- Nicholas Investment Partners's Guardant Health position peaked at $23.6M in Q1 2021.
- 600 funds tracked by Wall St. Rank held Guardant Health as of Q2 2026.
Based on Nicholas Investment Partners's 13F filing for Q2 2026, filed 14 Aug 2026.